CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 88 filers reported holding CUREVAC N V in Q2 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,481,202 | +5.3% | 363,280 | +60.6% | 0.10% | +18.3% |
| Q2 2023 | $2,356,316 | +51.7% | 226,134 | +970.1% | 0.08% | +127.8% |
| Q2 2021 | $1,553,000 | -62.1% | 21,132 | -52.8% | 0.04% | -60.4% |
| Q1 2021 | $4,097,000 | +203.9% | 44,800 | +169.5% | 0.09% | +193.5% |
| Q4 2020 | $1,348,000 | -58.1% | 16,623 | -76.0% | 0.03% | -61.2% |
| Q3 2020 | $3,220,000 | – | 69,176 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |